(Q85030796)
Statements
Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: the RESET Trial (English)
Boulos Haraoui
Vivian P Bykerk
Maria Bokarewa
Ian Kallmeyer
RESET Investigators